Chemo renames itself Insud

Spain’s Chemo Group has renamed itself Insud Pharma, “a name that encompasses all of the different brands in our pharmaceutical business”. Under the Insud banner, the firm will integrate its three areas of business: Chemo, the group’s industrial division which develops and manufactures finished dosage-forms and active pharmaceutical ingredients (APIs); Exeltis, the branded sales and marketing arm; and mAbxience, specialising in biosimilar monoclonal antibodies.